Literature DB >> 24063262

Protein expression profiling of formalin-fixed paraffin-embedded tissue using recombinant antibody microarrays.

Frida Pauly1, Linda Dexlin-Mellby, Sara Ek, Mats Ohlin, Niclas Olsson, Karin Jirström, Michael Dictor, Saskia Schoenmakers, Carl A K Borrebaeck, Christer Wingren.   

Abstract

Proteomics, the large-scale analysis of proteins, is a rapidly evolving field with an increasing number of key clinical applications, such as diagnosis, prognosis, and classification. In order to generate complete protein expression profiles, or protein atlases, any crude sample format must be addressable in a rapid, multiplex, and sensitive manner. A common and clinically central sample format, formalin-fixed, paraffin-embedded (FFPE) tissue material, holds great potential as a source for disease-associated biomarker signatures. However, despite major efforts, extraction and subsequent profiling of proteins from FFPE tissue has proven to be challenging. In this proof-of-concept study, we have demonstrated for the first time that proteins could be extracted, labeled, and subsequently profiled in a multiplex, sensitive, and reproducible manner using recombinant scFv antibody microarrays. Thus, we have added FFPE samples to the list of sample formats available for high-throughput analysis by affinity proteomics, paving the way for the next generation of biomarker-driven discovery projects.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24063262     DOI: 10.1021/pr4003245

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  7 in total

1.  Plasma protein profiling in a stage defined pancreatic cancer cohort - Implications for early diagnosis.

Authors:  Anna Sandström Gerdtsson; Christer Wingren; Helena Persson; Payam Delfani; Malin Nordström; He Ren; Xin Wen; Ulrika Ringdahl; Carl A K Borrebaeck; Jihui Hao
Journal:  Mol Oncol       Date:  2016-07-12       Impact factor: 6.603

2.  Identification of plasma protein profiles associated with risk groups of prostate cancer patients.

Authors:  Malin Nordström; Christer Wingren; Carsten Rose; Anders Bjartell; Charlotte Becker; Hans Lilja; Carl A K Borrebaeck
Journal:  Proteomics Clin Appl       Date:  2014-10-22       Impact factor: 3.494

3.  Identification of a serum biomarker signature associated with metastatic prostate cancer.

Authors:  Venera Kuci Emruli; Leena Liljedahl; Ulrika Axelsson; Corinna Richter; Lisa Theorin; Anders Bjartell; Hans Lilja; Jenny Donovan; David Neal; Freddie C Hamdy; Carl A K Borrebaeck
Journal:  Proteomics Clin Appl       Date:  2021-05-04       Impact factor: 3.603

4.  Technical Advances of the Recombinant Antibody Microarray Technology Platform for Clinical Immunoproteomics.

Authors:  Payam Delfani; Linda Dexlin Mellby; Malin Nordström; Andreas Holmér; Mattias Ohlsson; Carl A K Borrebaeck; Christer Wingren
Journal:  PLoS One       Date:  2016-07-14       Impact factor: 3.240

5.  Older Age Predicts Worse Function 1 Year After an Acute Achilles Tendon Rupture: A Prognostic Multicenter Study on 391 Patients.

Authors:  Olof Westin; Simon Svedman; Eric Hamrin Senorski; Eleonor Svantesson; Katarina Nilsson-Helander; Jón Karlsson; Paul Ackerman; Kristian Samuelsson
Journal:  Orthop J Sports Med       Date:  2018-12-26

6.  Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease.

Authors:  Jonathan C Dunne; David S Lamb; Brett Delahunt; Judith Murray; Peter Bethwaite; Peter Ferguson; John N Nacey; Sven Sondhauss; T William Jordan
Journal:  Clin Proteomics       Date:  2015-09-16       Impact factor: 3.988

7.  ESE-1 in Early Development: Approaches for the Future.

Authors:  Chan Mi Lee; Jing Wu; Yi Xia; Jim Hu
Journal:  Front Cell Dev Biol       Date:  2016-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.